Cipla 444 (Atazanavir Sulfate 150 mg)
Pill with imprint Cipla 444 is Blue, Capsule-shape and has been identified as Atazanavir Sulfate 150 mg. It is supplied by Cipla USA Inc.
Atazanavir is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Atazanavir 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Cipla 444
Atazanavir Sulfate
- Imprint
- Cipla 444
- Strength
- 150 mg
- Color
- Blue
- Size
- 19.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Protease inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Cipla USA Inc.
- National Drug Code (NDC)
- 69097-0444
- Inactive Ingredients
-
lactose monohydrate,
crospovidone,
magnesium stearate,
gelatin,
sodium lauryl sulfate,
FD&C Blue No. 1,
FD&C Red No. 3,
FD&C Red No. 40,
titanium dioxide,
D&C Yellow No. 10,
shellac,
alcohol,
isopropyl alcohol,
butyl alcohol,
propylene glycol,
ammonia,
potassium hydroxide
Note: Inactive ingredients may vary.
More about atazanavir
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (2)
- Drug images
- Pricing & coupons
- En español
- Drug class: protease inhibitors
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.